通过海马的mTOR通路,p75NTR介导的慢性克制导致小鼠的压力诱导的类似抑郁的行为
Yu-Yuan Peng1, Can Tang2, Hai-Yan Wang3
1State Key Laboratory of Trauma and Chemical Poisoning, Daping Hospital, Army Medical University, Chongqing 400042, China; College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
Life sciences
|October 30, 2024
概括
在小鼠中改变p75神经质受体 (p75NTR) 水平,可以减少类似抑郁症的行为. 这表明p75NTR可能是通过调节神经元自和突触可塑性来治疗主要抑郁症的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 精神病学是一个精神病学.
背景情况:
- 重度抑郁症 (MDD) 是一种严重的情绪障碍,其机制尚不清楚.
- p75神经受体 (p75NTR) 与神经元的生存和死亡有关.
- 需要阐明p75NTR在抑郁症中的特定作用.
研究的目的:
- 研究p75NTR在抑郁症中的作用和机制.
- 探索p75NTR作为MDD的潜在治疗点.
主要方法:
- 使用慢性克制压力 (CRS) 建立了小鼠抑郁症模型.
- 使用了p75NTR淘汰和过度表达的小鼠模型.
- 通过动物行为,组织病理学,免疫光和西部斑点评估行为效应和分子机制.
主要成果:
- p75NTR淘汰/过度表达改善了CRS诱导的类似抑郁的行为.
- 调节p75NTR保护的海马体形态,抑制mTOR信号传递,恢复自和正常化亡.
- p75NTR操纵通过保护神经元结构和向上调节突触蛋白 (PSD95,SYN1) 来增强海马突触可塑性.
结论:
- p75NTR淘汰/过度表达通过恢复海马体自和抑制亡来缓解类似抑郁症的行为.
- 通过mTOR途径增强海马突触可塑性是一个关键机制.
- p75NTR为临床抑郁症治疗提供了潜在的治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K


